The prospect of an existing therapeutic drug (with an expired patent) that could outperform any vaccine in the war against COVID posed a momentous threat to the pharmaceutical cartel. Among the features pharma companies most detest is low cost, and HCQ is about $10 per course.41 Compare that to more than $3000 per course for Dr. Fauci’s beloved remdesivir.
